ERBB2 and breast neoplasm: As NS1643 inhibited breast tumor growth and metastasis (Fig. 1) and because the metastatic potential is often associated with enhanced cell motility25, the inhibitory effect of NS1643 on cell migration and invasive capabilities was further examined with MDA-MB-231 (TNBC) and SKBR3 (HER2-positive) cell lines.